Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationPaul B. Chapman, Grant A. McArthur, Axel Hauschild et al.|New England Journal of Medicine|2011Cited by 7.7k
Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated MelanomaGeorgina V. Long, John M. Kirkwood, Axel Hauschild et al.|New England Journal of Medicine|2017Cited by 1.5k
COT drives resistance to RAF inhibition through MAP kinase pathway reactivationCory M. Johannessen, Levi A. Garraway, Jesse S. Boehm et al.|Nature|2010Cited by 1.4k
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)Elise A. Olsen, Sean Whittaker, Eric C. Vonderheid et al.|Blood|2007Cited by 1.4k
Completion Dissection or Observation for Sentinel-Node Metastasis in MelanomaMark B. Faries, Robert M. Elashoff, Richard Hoefer et al.|New England Journal of Medicine|2017Cited by 1.4k